Recently we developed a standardized, objective immunohistochemical (IHC) method to quantify expression of TCII, TCII-R and Ki-67, a well-established protein marker of cellular proliferation, in a variety of human malignant tumor xenograft tissues [24]. This evidence concerns the gene MKI67 and cancer.